Harrow Health (HROW) Revenue & Revenue Breakdown
Harrow Health Revenue Highlights
Latest Revenue (Y)
$199.61T
Latest Revenue (Q)
$63.74M
Main Segment (Y)
Other Revenue
Harrow Health Revenue by Period
Harrow Health Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $199.61T | 153321507.15% |
| 2023-12-31 | $130.19M | 46.95% |
| 2022-12-31 | $88.59M | 22.24% |
| 2021-12-31 | $72.48M | 48.30% |
| 2020-12-31 | $48.87M | -4.48% |
| 2019-12-31 | $51.16M | 23.67% |
| 2018-12-31 | $41.37M | 54.52% |
| 2017-12-31 | $26.77M | 34.26% |
| 2016-12-31 | $19.94M | 105.25% |
| 2015-12-31 | $9.72M | 485.21% |
| 2014-12-31 | $1.66M | 16502.46% |
| 2013-12-31 | $10.00K | -90.00% |
| 2012-12-31 | $100.00K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2007-12-31 | - | 100.00% |
| 2006-05-31 | - | - |
Harrow Health generated $199.61T in revenue during NA 2024, up 153321507.15% compared to the previous quarter, and up 390137789.50% compared to the same period a year ago.
Harrow Health Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $63.74M | 33.27% |
| 2025-03-31 | $47.83M | -28.43% |
| 2024-12-31 | $66.83M | 35.68% |
| 2024-09-30 | $49.26M | 0.65% |
| 2024-06-30 | $48.94M | 41.50% |
| 2024-03-31 | $34.59M | -4.86% |
| 2023-12-31 | $36.35M | 6.10% |
| 2023-09-30 | $34.27M | 2.38% |
| 2023-06-30 | $33.47M | 28.22% |
| 2023-03-31 | $26.10M | 28.40% |
| 2022-12-31 | $20.33M | -10.93% |
| 2022-09-30 | $22.82M | -2.14% |
| 2022-06-30 | $23.32M | 5.44% |
| 2022-03-31 | $22.12M | 9.57% |
| 2021-12-31 | $20.19M | 7.89% |
| 2021-09-30 | $18.71M | 3.18% |
| 2021-06-30 | $18.13M | 17.43% |
| 2021-03-31 | $15.44M | 5.81% |
| 2020-12-31 | $14.60M | 1.36% |
| 2020-09-30 | $14.40M | 78.65% |
| 2020-06-30 | $8.06M | -31.79% |
| 2020-03-31 | $11.82M | -6.24% |
| 2019-12-31 | $12.60M | -1.18% |
| 2019-09-30 | $12.76M | -5.63% |
| 2019-06-30 | $13.52M | 9.98% |
| 2019-03-31 | $12.29M | 7.96% |
| 2018-12-31 | $11.38M | 6.01% |
| 2018-09-30 | $10.74M | 3.42% |
| 2018-06-30 | $10.38M | 17.13% |
| 2018-03-31 | $8.87M | 20.83% |
| 2017-12-31 | $7.34M | 13.17% |
| 2017-09-30 | $6.48M | -5.45% |
| 2017-06-30 | $6.86M | 12.47% |
| 2017-03-31 | $6.10M | 5.25% |
| 2016-12-31 | $5.79M | 19.17% |
| 2016-09-30 | $4.86M | -0.94% |
| 2016-06-30 | $4.91M | 12.01% |
| 2016-03-31 | $4.38M | 25.06% |
| 2015-12-31 | $3.50M | 30.56% |
| 2015-09-30 | $2.68M | 36.40% |
| 2015-06-30 | $1.97M | 25.85% |
| 2015-03-31 | $1.56M | 184.13% |
| 2014-12-31 | $550.11K | 24.73% |
| 2014-09-30 | $441.03K | -33.95% |
| 2014-06-30 | $667.70K | 47254.68% |
| 2014-03-31 | $1.41K | -43.60% |
| 2013-12-31 | $2.50K | - |
| 2013-09-30 | $2.50K | - |
| 2013-06-30 | $2.50K | - |
| 2013-03-31 | $2.50K | 100.00% |
| 2012-12-31 | - | 100.00% |
| 2012-09-30 | - | 100.00% |
| 2012-06-30 | - | -100.00% |
| 2012-03-31 | $100.00K | 100.00% |
| 2011-12-31 | - | 100.00% |
| 2011-09-30 | - | 100.00% |
| 2011-06-30 | - | 100.00% |
| 2011-03-31 | - | 100.00% |
| 2010-12-31 | - | 100.00% |
| 2010-09-30 | - | 100.00% |
| 2010-06-30 | - | 100.00% |
| 2010-03-31 | - | 100.00% |
| 2009-12-31 | - | 100.00% |
| 2009-09-30 | - | 100.00% |
| 2009-06-30 | - | 100.00% |
| 2009-03-31 | - | 100.00% |
| 2008-12-31 | - | 100.00% |
| 2008-09-30 | - | 100.00% |
| 2008-06-30 | - | 100.00% |
| 2008-03-31 | - | 100.00% |
| 2007-12-31 | - | - |
Harrow Health generated $63.74M in revenue during Q2 2025, up 33.27% compared to the previous quarter, and up 184.29% compared to the same period a year ago.
Harrow Health Revenue Breakdown
Harrow Health Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Other Revenue | $915.00K | - | - | - | - |
| Other Revenues | - | $5.07M | $3.37M | $392.00K | - |
| License Revenues | - | - | - | - | $28.00K |
Latest
Harrow Health's latest annual revenue breakdown by segment (product or service), as of Dec 24: Other Revenue (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Mar 24 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Revenue | $85.00K | $86.00K | $687.00K | $228.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Products | $5.21M | $956.00K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Revenues | - | - | - | - | $79.00K | $3.93M | $5.65M | $238.00K | $1.25M | $1.80M | $1.78M | $1.14M | $837.00K | $495.00K | $360.00K | $14.00K | - | - | - | - |
| License Revenues | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $11.00K | $7.00K | $7.00K | $7.00K |
Latest
Harrow Health's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: Other Products (98.40%), and Other Revenue (1.60%).
Harrow Health Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HROW | Harrow Health | $199.61T | $63.74M |
| CLOV | Clover Health Investments | $1.37B | $477.62M |
| PAHC | Phibro Animal Health | $1.30B | $309.26M |
| EVO | Evotec SE | $781.43M | $208.73M |
| NVAX | Novavax | $682.16M | $239.24M |
| ANIP | ANI Pharmaceuticals | $614.38M | $197.12M |
| NVCR | NovoCure | $605.22M | $154.99M |
| DVAX | Dynavax | $277.25M | $68.16M |
| AUPH | Aurinia Pharmaceuticals | $235.13M | $70.01M |
| SDGR | Schrödinger | $207.54M | $59.55M |
| AVDL | Avadel Pharmaceuticals | $169.12M | $52.51M |